Jieni Xu

796 total citations
22 papers, 636 citations indexed

About

Jieni Xu is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Jieni Xu has authored 22 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomedical Engineering, 12 papers in Molecular Biology and 10 papers in Biomaterials. Recurrent topics in Jieni Xu's work include Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (10 papers) and RNA Interference and Gene Delivery (6 papers). Jieni Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (10 papers) and RNA Interference and Gene Delivery (6 papers). Jieni Xu collaborates with scholars based in United States and China. Jieni Xu's co-authors include Song Li, Jingjing Sun, Yixian Huang, Xiaochao Ma, Zhuoya Wan, Zhangyi Luo, Yichao Chen, Da Yang, Yue Wang and Min Zhang and has published in prestigious journals such as Nature Communications, Biomaterials and Journal of Controlled Release.

In The Last Decade

Jieni Xu

21 papers receiving 626 citations

Peers

Jieni Xu
Melissa M. Sprachman United States
Janani Panneerselvam United States
Saini Setua United States
Thillai V. Sekar United States
Joseph Burnett United States
Melissa M. Sprachman United States
Jieni Xu
Citations per year, relative to Jieni Xu Jieni Xu (= 1×) peers Melissa M. Sprachman

Countries citing papers authored by Jieni Xu

Since Specialization
Citations

This map shows the geographic impact of Jieni Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieni Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieni Xu more than expected).

Fields of papers citing papers by Jieni Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieni Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieni Xu. The network helps show where Jieni Xu may publish in the future.

Co-authorship network of co-authors of Jieni Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jieni Xu. A scholar is included among the top collaborators of Jieni Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieni Xu. Jieni Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ziqian, Zhangyi Luo, Haozhe Huang, et al.. (2024). YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy. Biomacromolecules. 26(1). 266–278. 1 indexed citations
2.
Sun, Jingjing, Zhuoya Wan, Jieni Xu, et al.. (2020). Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer. Biomaterials. 269. 120629–120629. 41 indexed citations
3.
Qu, Qiu‐Xia, Zhiwei Zhai, Jieni Xu, et al.. (2020). IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses. Frontiers in Immunology. 11. 634–634. 21 indexed citations
4.
Luo, Zhangyi, Jieni Xu, Jingjing Sun, et al.. (2020). Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer. Acta Biomaterialia. 105. 239–252. 39 indexed citations
5.
Sun, Jingjing, Zhuoya Wan, Yichao Chen, et al.. (2020). Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. Acta Biomaterialia. 106. 289–300. 41 indexed citations
6.
Ma, Weina, Jingjing Sun, Jieni Xu, et al.. (2020). Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier. Theranostics. 10(6). 2463–2478. 39 indexed citations
8.
Wan, Zhuoya, Jingjing Sun, Jieni Xu, et al.. (2019). Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy. Acta Biomaterialia. 90. 300–313. 51 indexed citations
9.
Sun, Jingjing, Yichao Chen, Jieni Xu, et al.. (2019). High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy. Theranostics. 10(3). 1136–1150. 31 indexed citations
10.
Xu, Jieni, Jingjing Sun, Pui Yan Ho, et al.. (2019). Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis. Biomaterials. 210. 25–40. 34 indexed citations
11.
Wan, Zhuoya, Jingjing Sun, Jieni Xu, et al.. (2019). Dual Functional Immunostimulatory Polymeric Prodrug Carrier with Pendent Indoximod for Enhanced Cancer Immunochemotherapy. SSRN Electronic Journal. 1 indexed citations
12.
Xu, Jieni, Jingjing Sun, Yixian Huang, et al.. (2018). Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents. Journal of Controlled Release. 288. 212–226. 14 indexed citations
13.
Sun, Jingjing, Lingyi Sun, Jianchun Li, et al.. (2018). A multi-functional polymeric carrier for simultaneous positron emission tomography imaging and combination therapy. Acta Biomaterialia. 75. 312–322. 28 indexed citations
14.
Wang, Yue, Zehua Wang, Jieni Xu, et al.. (2018). Systematic identification of non-coding pharmacogenomic landscape in cancer. Nature Communications. 9(1). 3192–3192. 77 indexed citations
15.
Li, Zuojun, Jingjing Sun, Yixian Huang, et al.. (2018). A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin. Frontiers in Pharmacology. 9. 781–781. 14 indexed citations
16.
Xu, Jieni, et al.. (2017). Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs. Journal of drug targeting. 26(5-6). 448–457. 27 indexed citations
17.
Chen, Yichao, Jieni Xu, Yixian Huang, et al.. (2017). Lymphoma Immunochemotherapy: Targeted Delivery of Doxorubicin via a Dual Functional Nanocarrier. Molecular Pharmaceutics. 14(11). 3888–3895. 28 indexed citations
18.
Xu, Jieni, Xiaolan Zhang, Yichao Chen, et al.. (2016). Improved Micellar Formulation for Enhanced Delivery for Paclitaxel. Molecular Pharmaceutics. 14(1). 31–41. 17 indexed citations
19.
Zhao, Min, Yixian Huang, Yichao Chen, et al.. (2016). PEG-Fmoc-Ibuprofen Conjugate as a Dual Functional Nanomicellar Carrier for Paclitaxel. Bioconjugate Chemistry. 27(9). 2198–2205. 19 indexed citations
20.
Lu, Jianqin, Chuang Liu, Pengcheng Wang, et al.. (2015). The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin. Biomaterials. 62. 176–187. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026